Letters

Naming of drugs

BMJ 1996; 313 doi: https://doi.org/10.1136/bmj.313.7058.688 (Published 14 September 1996) Cite this as: BMJ 1996;313:688

Differences between nomenclatures are much greater than editorial suggested

  1. Fernando A Navarro, Clinical pharmacologist
  1. F Hoffmann-La Roche, CH-4070 Basle, Switzerland

    EDITOR,—C F George discusses the difficulties that will result from the European Commission's directive which states that the international non-proprietary name, not the British approved name, must appear on the labels and leaflets of medicinal products from January 1998.1 George underestimates the problem, however, in asserting that “in total, 41 drugs have a British approved name that is significantly different to their recommended international non-proprietary name.” I recently reviewed this issue and compared the official listings of the British approved names and the international non-proprietary …

    View Full Text

    Sign in

    Log in through your institution

    Subscribe